PRFT) Repurchase proposal and encourages shareholders to contact the firm

PHILADELPHIA CREAM, June 12, 2024 /PRNewswire/ — Kaskela Law LLC announces that it is investigating the recently announced investor buyout of Perficient, Inc. (NASDAQ: PRFT) on behalf of the Company’s shareholders.

On May 5, 2024Perficient announced that it had agreed to be acquired by private investment entity BPEA Private Equity Fund VIII at a price of $76.00 per share in liquid. Following the closing of the proposed transaction, Perficient’s current shareholders will be removed from their investment positions and the company’s shares will no longer be traded on the stock exchange.

The investigation conducted to date has revealed that the process leading to the announcement of the buyout appears to involve significant conflicts of interest, making the sale process and the price per share appear unfair in the eyes of investors. shareholders of the company. Notably, at the time the proposed transaction was announced, a stock analyst had set a price target for PRFT shares of $92.00 per share.

Perficient Shareholders who believe the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. Or Adrienne Bell, Esq.) at (484) 229 – 0750 or (888) 715 – 1740 for more information about this investigation and their legal rights and options, or by clicking on the following link (or copying and pasting the link into your browser):

https://kaskelalaw.com/case/perficient/

Kaskela Law LLC exclusively represents securities investors fraud, corporate governance and mergers and acquisitions litigation on a conditional basis. For more information about Kaskela Law LLC, please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
((email protected))
Adrienne Bell, Esq.
((email protected))
18, boulevard Campus, bureau 100
Newtown Square, Pennsylvania 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

This notice may constitute attorney advertising in some jurisdictions.

SOURCE Kaskela Law LLC